Casdin Capital as of Dec. 31, 2022
Portfolio Holdings for Casdin Capital
Casdin Capital holds 44 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sarepta Therapeutics (SRPT) | 13.2 | $170M | 1.3M | 129.58 | |
| Biolife Solutions Com New (BLFS) | 10.7 | $138M | 7.6M | 18.20 | |
| Eqrx | 7.5 | $97M | 40M | 2.46 | |
| Alnylam Pharmaceuticals (ALNY) | 6.7 | $87M | 365k | 237.65 | |
| Illumina (ILMN) | 6.0 | $78M | 385k | 202.20 | |
| Blueprint Medicines (BPMC) | 5.0 | $65M | 1.5M | 43.81 | |
| Revolution Medicines (RVMD) | 4.7 | $60M | 2.5M | 23.82 | |
| Maxcyte (MXCT) | 4.0 | $52M | 9.5M | 5.46 | |
| Relay Therapeutics (RLAY) | 3.5 | $45M | 3.0M | 14.94 | |
| Verve Therapeutics (VERV) | 3.4 | $44M | 2.3M | 19.35 | |
| Denali Therapeutics (DNLI) | 2.8 | $36M | 1.3M | 27.81 | |
| Pliant Therapeutics (PLRX) | 2.5 | $32M | 1.7M | 19.33 | |
| Somalogic Class A Com | 2.5 | $32M | 13M | 2.51 | |
| EXACT Sciences Corporation (EXAS) | 2.2 | $28M | 565k | 49.51 | |
| Mirati Therapeutics Call Option | 2.0 | $26M | 575k | 45.31 | |
| Abcellera Biologics (ABCL) | 1.8 | $23M | 2.3M | 10.13 | |
| Twist Bioscience Corp (TWST) | 1.7 | $23M | 945k | 23.81 | |
| Fate Therapeutics (FATE) | 1.6 | $21M | 2.1M | 10.09 | |
| Avidity Biosciences Ord (RNA) | 1.5 | $19M | 850k | 22.19 | |
| 2seventy Bio Common Stock | 1.3 | $17M | 1.9M | 9.37 | |
| Invitae (NVTAQ) | 1.3 | $17M | 9.0M | 1.86 | |
| Prometheus Biosciences | 1.3 | $17M | 150k | 110.00 | |
| Century Therapeutics (IPSC) | 1.3 | $16M | 3.2M | 5.13 | |
| Moderna (MRNA) | 1.3 | $16M | 90k | 179.62 | |
| Absci Corp (ABSI) | 1.2 | $16M | 7.4M | 2.10 | |
| Beam Therapeutics (BEAM) | 1.1 | $15M | 370k | 39.11 | |
| 4d Molecular Therapeutics In (FDMT) | 1.1 | $14M | 630k | 22.21 | |
| Prime Medicine (PRME) | 1.1 | $14M | 734k | 18.58 | |
| Tenaya Therapeutics (TNYA) | 0.9 | $12M | 6.1M | 2.01 | |
| Intellia Therapeutics (NTLA) | 0.8 | $10M | 295k | 34.89 | |
| Veeva Sys Cl A Com (VEEV) | 0.6 | $8.1M | 50k | 161.38 | |
| Arvinas Ord (ARVN) | 0.5 | $6.8M | 200k | 34.21 | |
| Incyte Corporation (INCY) | 0.5 | $6.2M | 78k | 80.32 | |
| Dice Therapeutics | 0.4 | $5.1M | 165k | 31.20 | |
| Optimizerx Corp Com New (OPRX) | 0.3 | $4.4M | 260k | 16.80 | |
| Sema4 Holdings Corp Com Cl A | 0.3 | $4.3M | 16M | 0.26 | |
| Definitive Healthcare Corp Class A Com (DH) | 0.3 | $4.0M | 360k | 10.99 | |
| Monte Rosa Therapeutics (GLUE) | 0.3 | $3.9M | 511k | 7.61 | |
| Keros Therapeutics (KROS) | 0.2 | $3.1M | 65k | 48.02 | |
| Singular Genomics Systems In | 0.2 | $2.7M | 1.3M | 2.01 | |
| Wave Life Sciences SHS (WVE) | 0.1 | $1.4M | 200k | 7.00 | |
| Exscientia Ads (EXAI) | 0.1 | $1.1M | 214k | 5.33 | |
| Lianbio Sponsored Ads (LIANY) | 0.0 | $339k | 206k | 1.64 | |
| Kronos Bio | 0.0 | $201k | 124k | 1.62 |
